about
Zika virus and microcephaly in Brazil: a scientific agendaBalance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesisImmunoregulation in human malaria: the challenge of understanding asymptomatic infectionLutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermediaEnhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva.Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva.Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severityImmunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis.BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.Severe Plasmodium vivax malaria exhibits marked inflammatory imbalanceCan score databanks help teaching?SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis.Towards a precise test for malaria diagnosis in the Brazilian Amazon: comparison among field microscopy, a rapid diagnostic test, nested PCR, and a computational expert system based on artificial neural networksHepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon.DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malariaSerological survey of Leishmania infection in blood donors in Salvador, Northeastern Brazil.Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen.Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis.Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis.Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteinsVaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamstersLesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis.Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation.Vaccines in leishmaniasis: advances in the last five years.Medical Specialty Choice and Related Factors of Brazilian Medical Students and Recent DoctorsAssociation between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria.Heme oxygenase-1 promotes the persistence of Leishmania chagasi infectionUnravelling the patterns of host immune responses in Plasmodium vivax malaria and dengue co-infection.Associations between hepcidin and immune response in individuals with hyperbilirubinaemia and severe malaria due to Plasmodium vivax infection.Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous LeishmaniasisHaematophagous arthropod saliva and host defense system: a tale of tear and blood.The host genetic diversity in malaria infection.Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells.Networking the host immune response in Plasmodium vivax malaria.CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasisSeroconversion of sentinel chickens as a biomarker for monitoring exposure to visceral leishmaniasis.Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon
P50
Q24247070-06375C0E-CA07-40FC-95FB-B9E28D955BD7Q25256772-C366725B-BB4C-472D-9456-F095CA5D99B7Q26775212-6DE7EAC5-6A5F-48EE-8636-9E2AC0E36A0DQ27306221-45C49E82-466D-4EA0-878B-C7AF62DC9263Q33308759-63D00AE4-C50F-4D4B-BBA0-A8D1A292300EQ33327586-74A6B04B-9C64-40C7-83A1-9C989C044274Q33547356-5B591594-2101-40C4-9A5B-282BC1578DABQ33553168-CFDE139F-9392-4908-955E-D0DBF4269AD8Q33608744-1BE628EE-6F3C-414D-ACC5-DE0759FD9A23Q33633286-3BF4A5D4-010C-45E5-8BDF-E289253E4BB4Q33721525-71516ACF-CE69-406A-9DF8-40C256A115E3Q33796630-8C1C0F6A-3D5C-4037-8C69-474D54BC262DQ33816072-E5C8B332-550C-4BEC-B598-FDC2FA924C5BQ33905358-4EF121ED-60CC-4AC1-AA08-1D349B199E3BQ33916831-678085E9-CDAC-495F-B6B3-930EA0382E1BQ33957344-83F33706-4D83-4832-8C8F-6FB65561FB4CQ34006836-37A5A77B-362E-42CC-90B9-14A86D74CFB4Q34013495-F80F6FD7-3C78-4199-B316-C46BEB691F24Q34160109-FB249D38-02B3-46B5-ADE8-B1382491EF6FQ34314499-96235FA8-986B-4D52-BEB0-5CE5736E21FEQ34533591-DC185BAB-152A-496D-ACBD-9469BB4571B3Q34663797-FFF26BE7-3D72-423D-8B32-BAD08646B47BQ34776318-16CF5522-A028-4E67-A7F3-6A3F321B655AQ35038313-343A8277-1FDF-4DC8-8A7A-76431939CA20Q35065591-B4C3941E-572F-4BE6-AC03-4DB0A624AD06Q35532615-6BA85735-FE29-4B0C-9EF1-571783539F77Q35623310-DB0C4A4C-9BC8-48FC-AFEF-F737C1E3F81FQ35711435-223583F8-CD55-4327-A4D1-C18D5DB92AD8Q35867634-4F8C873A-A5CC-4DE3-922F-B7B844E0C3A4Q35903321-24E11288-D0BC-4897-8758-2CA8650C3D26Q35953957-42E2A108-F288-443F-B3E7-7742CCD9CBA4Q36165235-D0A483BF-0C58-440C-8645-013D15A4E631Q36199662-B33ECFEB-BCF4-4E21-A6A2-1CD290166460Q36338123-12B63C6A-4BD6-4BE6-99E8-A0FB5B4B8071Q36495726-6DD499FB-6DB8-4E2E-A44C-51C44E40BB2DQ36576090-E443C93C-E89E-4A88-996D-08AF55CF780FQ36686824-99DCC57C-E63D-43EE-8091-A488C7D0081BQ36886086-87627507-316D-4044-B040-EED53ACBBEE6Q37068873-D2554A80-B3DE-45BE-83D0-C413F4A02D94Q37234934-E47259DD-66CD-4969-9B86-37876BE79952
P50
name
Manoel Barral-Netto
@en
Manoel Barral-Netto
@es
type
label
Manoel Barral-Netto
@en
Manoel Barral-Netto
@es
prefLabel
Manoel Barral-Netto
@en
Manoel Barral-Netto
@es